{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:04:55Z","timestamp":1787699095265,"version":"build-2784847793"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003065","name":"Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011039","name":"Swiss Centre for Applied Human Toxicology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bcp.2019.113781","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T19:51:21Z","timestamp":1577389881000},"page":"113781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis"],"prefix":"10.1016","volume":"172","author":[{"given":"Melanie","family":"Patt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christin","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gonz\u00e1lez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Boccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rudaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf W.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"van Koppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bcp.2019.113781_b0005","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1210\/jcem.86.11.7983","article-title":"Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases","volume":"86","author":"Basaria","year":"2001","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1079\/BJN19960116","article-title":"Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection","volume":"75","author":"Hengge","year":"1996","journal-title":"British J. Nutr."},{"issue":"6","key":"10.1016\/j.bcp.2019.113781_b0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.283.6.763","article-title":"Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels","volume":"283","author":"Bhasin","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bcp.2019.113781_b0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1468-1293.2006.00358.x","article-title":"Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting","volume":"7","author":"Gold","year":"2006","journal-title":"HIV medicine"},{"issue":"3","key":"10.1016\/j.bcp.2019.113781_b0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncpendmet0120","article-title":"Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging","volume":"2","author":"Bhasin","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.114.1.19","article-title":"The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients","volume":"114","author":"Ferreira","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2019.113781_b0035","article-title":"The role of anabolic hormones for wound healing in catabolic states","volume":"4","author":"Demling","year":"2005","journal-title":"Journal of burns and wounds"},{"issue":"5","key":"10.1016\/j.bcp.2019.113781_b0040","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"12","key":"10.1016\/j.bcp.2019.113781_b0045","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jsxm.2017.10.067","article-title":"British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency","volume":"14","author":"Hackett","year":"2017","journal-title":"With Statements for UK Practice, The journal of sexual medicine"},{"key":"10.1016\/j.bcp.2019.113781_b0050","series-title":"Anabolic-Androgenic Steroids","first-page":"361","article-title":"Dissociation of the Androgenic and Other Hormonal Activities from the Protein Anabolic Effects of Steroids","author":"Potts","year":"1976"},{"issue":"11","key":"10.1016\/j.bcp.2019.113781_b0055","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1210\/en.2005-0572","article-title":"Selective Androgen Receptor Modulator Treatment Improves Muscle Strength and Body Composition and Prevents Bone Loss in Orchidectomized Rats","volume":"146","author":"Gao","year":"2005","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","article-title":"Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators","volume":"25","author":"Smith","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2019.113781_b0065","unstructured":"NIH, U.S., National, Library, of, Medicine, Clinical Trials, [Online] https:\/\/www.clinicaltrials.gov [Accessed: September, 2019]."},{"key":"10.1016\/j.bcp.2019.113781_b0070","unstructured":"World, Anti-Doping, Agency, Adverse analytical findings reported by accredited laboratories, [Online] http:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2017_anti doping_testing_figures_en_0.pdf (2017) [Accessed: November, 2018]."},{"key":"10.1016\/j.bcp.2019.113781_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","article-title":"History and epidemiology of anabolic androgens in athletes and non-athletes","volume":"464","author":"Kanayama","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2019.113781_b0080","doi-asserted-by":"crossref","unstructured":"J.E. Schulenberg, L.D. Johnston, P.M. O\u2019Malley, J.G. Bachman, R.A. Miech, M.E. Patrick, Monitoring the Future - National Survey Results on Drug Use: College Students and Adults Ages 19-55, [Online] http:\/\/monitoringthefuture.org\/\/pubs\/monographs\/mtf-vol2_2017.pdf (2017) [Accessed: November, 2018].","DOI":"10.3998\/2027.42\/146531"},{"key":"10.1016\/j.bcp.2019.113781_b0085","unstructured":"A. Donati, World traffic in doping substances, [Online] https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/WADA_Donati_Report_On_Trafficking_2007.pdf (2007) [Accessed: November, 2018]."},{"issue":"7","key":"10.1016\/j.bcp.2019.113781_b0090","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.3390\/ijerph8072656","article-title":"Anabolic androgenic steroids\u2013use and correlates among gym users\u2013an assessment study using questionnaires and observations at gyms in the Stockholm region","volume":"8","author":"Leifman","year":"2011","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bcp.2019.113781_b0095","first-page":"505","volume":"38","author":"Graham","year":"2008","journal-title":"Anabolic Steroid Use"},{"issue":"2","key":"10.1016\/j.bcp.2019.113781_b0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/edrv-9-2-181","article-title":"Androgen abuse by athletes","volume":"9","author":"Wilson","year":"1988","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bcp.2019.113781_b0105","first-page":"571","volume":"19","author":"Trenton","year":"2005","journal-title":"Behavioural Manifestations of Anabolic Steroid Use"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0110","first-page":"55","article-title":"Anabolic steroids, Bailliere's best practice & research","volume":"14","author":"Mottram","year":"2000","journal-title":"Clinical endocrinology & metabolism"},{"issue":"3","key":"10.1016\/j.bcp.2019.113781_b0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2019.113781_b0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.toxlet.2005.06.005","article-title":"Adverse effects of anabolic steroids in athletes: A constant threat","volume":"158","author":"Maravelias","year":"2005","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2019.113781_b0125","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-3-540-79088-4_19","article-title":"Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships","volume":"195","author":"Buttner","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bcp.2019.113781_b0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-3-540-79088-4_18","article-title":"Androgenic anabolic steroid abuse and the cardiovascular system","volume":"195","author":"Vanberg","year":"2010","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-0620(98)80019-4","article-title":"The cardiac toxicity of anabolic steroids","volume":"41","author":"Sullivan","year":"1998","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"4652","key":"10.1016\/j.bcp.2019.113781_b0140","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1126\/science.6326265","article-title":"Androgen modulation of adrenal angiotensin receptors","volume":"224","author":"Carroll","year":"1984","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/07435807809073637","article-title":"The Occurrence of 11-Deoxycorticosterone (DOC)-Induced Hypertension in the Long-Evans Rat","volume":"5","author":"Brownie","year":"1978","journal-title":"Endocrine Research Communications"},{"issue":"2","key":"10.1016\/j.bcp.2019.113781_b0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/07435809209035404","article-title":"The inhibition of rat adrenal cytochrome P-45011 beta gene expression by androgens","volume":"18","author":"Gallant","year":"1992","journal-title":"Endocr Res"},{"issue":"12","key":"10.1016\/j.bcp.2019.113781_b0155","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1172\/JCI105499","article-title":"17-hydroxylation deficiency in man","volume":"45","author":"Biglieri","year":"1966","journal-title":"J. Clin. Investig."},{"issue":"13","key":"10.1016\/j.bcp.2019.113781_b0160","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM196709282771302","article-title":"Hypogonadism and Mineralocorticoid Excess","volume":"277","author":"Goldsmith","year":"1967","journal-title":"N. Engl. J. Med."},{"issue":"28","key":"10.1016\/j.bcp.2019.113781_b0165","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1200\/JCO.2007.15.9749","article-title":"Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven","volume":"26","author":"Attard","year":"2008","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.bcp.2019.113781_b0170","series-title":"3rd","first-page":"104311","author":"Beck","year":"2019"},{"key":"10.1016\/j.bcp.2019.113781_b0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tox.2017.02.010","article-title":"Steroid profiling in H295R cells to identify chemicals potentially disrupting the production of adrenal steroids","volume":"381","author":"Strajhar","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2019.113781_b0180","article-title":"Novel Protective Group Synthesis of Androgen Receptor Modulators with Steroidal and Nonsteroidal Scaffolds","author":"Grill","year":"2019","journal-title":"ChemRxiv reprint"},{"key":"10.1016\/j.bcp.2019.113781_b0185","article-title":"Oecd guideline for the testing of chemicals. Test No. 456: H295R Steroidogenesis Assay, OECD Guidelines for the Testing of Chemicals, Section 4","author":"OECD","year":"2011","journal-title":"Health Effects"},{"key":"10.1016\/j.bcp.2019.113781_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.04.007","article-title":"Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11beta-hydroxylase and aldosterone synthase","author":"Akram","year":"2019","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0960-0760(00)00137-0","article-title":"Development of a simple and rapid assay for the evaluation of inhibitors of human 17alpha-hydroxylase-C(17,20)-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coli","volume":"75","author":"Ehmer","year":"2000","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14756360310001640913","article-title":"Synthesis of hydroxy derivatives of highly potent non-steroidal CYP 17 inhibitors as potential metabolites and evaluation of their activity by a non cellular assay using recombinant human enzyme","volume":"19","author":"Hutschenreuter","year":"2004","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7383","key":"10.1016\/j.bcp.2019.113781_b0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","article-title":"Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.bcp.2019.113781_b0210","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1074\/jbc.M117.792465","article-title":"Functional analysis of human cytochrome P450 21A2 variants involved in congenital adrenal hyperplasia","volume":"292","author":"Wang","year":"2017","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"10.1016\/j.bcp.2019.113781_b0215","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/jpet.107.131904","article-title":"Activation and inhibition of adenylyl cyclase isoforms by forskolin analogs","volume":"325","author":"Pinto","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.bcp.2019.113781_b0230","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/toxsci\/kfm055","article-title":"Sensitivity of fetal rat testicular steroidogenesis to maternal prochloraz exposure and the underlying mechanism of inhibition","volume":"97","author":"Blystone","year":"2007","journal-title":"Toxicological sciences : an official journal of the Society of Toxicology"},{"issue":"Pt A","key":"10.1016\/j.bcp.2019.113781_b0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsbmb.2015.09.038","article-title":"Computational analysis of liquid chromatography-tandem mass spectrometric steroid profiling in NCI H295R cells following angiotensin II, forskolin and abiraterone treatment","volume":"155","author":"Mangelis","year":"2016","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"issue":"3","key":"10.1016\/j.bcp.2019.113781_b0240","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1677\/JOE-07-0166","article-title":"Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3beta-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities","volume":"195","author":"Samandari","year":"2007","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0245","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00216-007-1657-5","article-title":"Novel trends in endocrine disruptor testing: the H295R Steroidogenesis Assay for identification of inducers and inhibitors of hormone production","volume":"390","author":"Hecker","year":"2008","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.bcp.2019.113781_b0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2016.08.035","article-title":"Structural insights into the function of steroidogenic cytochrome P450 17A1","volume":"441","author":"Yadav","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"13","key":"10.1016\/j.bcp.2019.113781_b0255","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1074\/jbc.M111.323501","article-title":"Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants","volume":"287","author":"Zhao","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"10.1016\/j.bcp.2019.113781_b0260","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/0002-9149(79)90224-8","article-title":"Echocardiographic dimensions in borderline and sustained hypertension","volume":"44","author":"Safar","year":"1979","journal-title":"The American journal of cardiology"},{"issue":"1","key":"10.1016\/j.bcp.2019.113781_b0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jsbmb.2004.11.003","article-title":"Effects of chronic anabolic steroid treatment on tonic and reflex cardiovascular control in male rats","volume":"93","author":"Beutel","year":"2005","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"issue":"10","key":"10.1016\/j.bcp.2019.113781_b0270","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2010.123","article-title":"Salt, aldosterone, and insulin resistance: impact on the cardiovascular system","volume":"7","author":"Lastra","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.bcp.2019.113781_b0275","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"Briet","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"issue":"21","key":"10.1016\/j.bcp.2019.113781_b0280","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"4","key":"10.1016\/j.bcp.2019.113781_b0285","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"The New England journal of medicine"},{"issue":"6","key":"10.1016\/j.bcp.2019.113781_b0290","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17843286.2018.1543827","article-title":"Abiraterone and spironolactone in prostate cancer: a combination to avoid","volume":"74","author":"Dhondt","year":"2019","journal-title":"Acta Clin. Belg."},{"issue":"6","key":"10.1016\/j.bcp.2019.113781_b0295","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1158\/1078-0432.CCR-14-1220","article-title":"Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors","volume":"21","author":"Chen","year":"2015","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"8","key":"10.1016\/j.bcp.2019.113781_b0300","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1021\/tx3001779","article-title":"Screening for modulatory effects on steroidogenesis using the human H295R adrenocortical cell line: a metabolomics approach","volume":"25","author":"Rijk","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"27","key":"10.1016\/j.bcp.2019.113781_b0305","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1021\/jm981017j","article-title":"The 16,17-double bond is needed for irreversible inhibition of human cytochrome p45017alpha by abiraterone (17-(3-pyridyl)androsta-5, 16-dien-3beta-ol) and related steroidal inhibitors","volume":"41","author":"Jarman","year":"1998","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113781_b0310","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/bbrc.1997.6113","article-title":"Protein phosphorylation changes ligand-binding efficiency of cytochrome P450c17 (CYP17) and accelerates its proteolytic degradation: putative relevance for hormonal regulation of CYP17 activity","volume":"231","author":"Lohr","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2019.113781_b0315","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1074\/jbc.M209527200","article-title":"Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17","volume":"278","author":"Pandey","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"33","key":"10.1016\/j.bcp.2019.113781_b0320","doi-asserted-by":"crossref","first-page":"23903","DOI":"10.1074\/jbc.M113.460048","article-title":"Phosphorylation of human cytochrome P450c17 by p38alpha selectively increases 17,20 lyase activity and androgen biosynthesis","volume":"288","author":"Tee","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2019.113781_b0325","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.bcp.2019.113781_b0330","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/S0021-9258(19)69538-4","article-title":"Microsomal cytochrome P-450 from neonatal pig testis. Purification and properties of A C21 steroid side-chain cleavage system (17 alpha-hydroxylase-C17,20 lyase)","volume":"256","author":"Nakajin","year":"1981","journal-title":"The Journal of biological chemistry"},{"issue":"2","key":"10.1016\/j.bcp.2019.113781_b0335","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0006-291X(82)90850-6","article-title":"Cytochrome b5 stimulates purified testicular microsomal cytochrome P-450 (C21 side-chain cleavage)","volume":"108","author":"Onoda","year":"1982","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.bcp.2019.113781_b0340","doi-asserted-by":"crossref","first-page":"13265","DOI":"10.1074\/jbc.M414673200","article-title":"Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17","volume":"280","author":"Pandey","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113781_b0345","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.steroids.2008.10.010","article-title":"Mineralocorticoid receptors: emerging complexity and functional diversity","volume":"74","author":"Odermatt","year":"2009","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.bcp.2019.113781_b0350","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.bcp.2019.113781_b0355","unstructured":"Merck, Canada, Inc., Andriol - Product Monograph, [Online] https:\/\/www.merck.ca\/static\/pdf\/ANDRIOL-PM_E.pdf (2017) [Accessed: September, 2019]."},{"issue":"2","key":"10.1016\/j.bcp.2019.113781_b0360","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2164\/jandrol.111.013169","article-title":"Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation","volume":"33","author":"Yin","year":"2012","journal-title":"Journal of andrology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:12:14Z","timestamp":1757769134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219304800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":72,"alternative-id":["S0006295219304800"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113781","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113781"}}